Harness the unique immunomodulatory power of dendritic cells for advanced gene delivery. From precise genetic engineering to functional validation, our platforms enable next-generation research in immuno-oncology, vaccinology, and immune tolerance.
Dendritic Cells: Nature’s Gene Delivery Platform
Dendritic cells (DCs) are the master regulators of adaptive immunity, uniquely capable of capturing, processing, and presenting antigens to T cells. This innate homing to lymphoid organs and potent T-cell priming ability makes them ideal vehicles for targeted gene delivery in research settings. By genetically modifying DCs ex vivo, they can be programmed to express specific antigens, immunomodulatory proteins, or even gene-editing tools, enabling precise interrogation of immune responses in both in vitro and in vivo models.
At Creative Biolabs, we offer comprehensive services for developing engineered dendritic cells as gene delivery systems. Our platforms cover everything from primary DC isolation and culture to advanced genetic modification (viral/non-viral) and rigorous functional validation—all exclusively for research use. Whether you are studying tumor immunology, autoimmunity, or vaccine development, our customizable DC solutions accelerate your discoveries.
Immune Precision
DCs naturally home to secondary lymphoid organs and present antigens via MHC molecules, ensuring targeted delivery of genetic payloads to the immune system.
Plasticity
DCs can be polarized toward immunogenic (mature) or tolerogenic phenotypes, allowing you to model immune activation or suppression as needed.
Versatile Engineering
Combine with viral vectors (lentivirus, adenovirus), mRNA electroporation, or nanoparticles to introduce genes encoding antigens, cytokines, or reporters.
Engineered DC Development Services
DC Isolation & Culture
High-quality, viable dendritic cells are the foundation of successful engineering.
We offer isolation of primary DCs from human (PBMC-derived CD14+ monocytes) or murine (bone marrow, spleen) sources. Alternatively, we can work with established DC lines (e.g., JAWSII, DC2.4) per your specifications.
Standardized cytokine cocktails (GM-CSF, IL-4, TNF-α, LPS, etc.) to generate immature or mature DCs with defined phenotypes (CD11c+, MHC-II+, CD80/86+). We also provide protocols for tolerogenic DC differentiation using IL-10, TGF-β, or dexamethasone.
Each batch is characterized by flow cytometry (purity >90%), viability (>85%), and endotoxin testing (<1 EU/mL) to ensure reproducibility.
Genetic Modification Platforms
Tailored strategies to introduce genes of interest into DCs with high efficiency and minimal toxicity.
We design and produce lentiviral (LV) and adenoviral (AdV) vectors encoding your antigen, cytokine, or reporter. LV enables stable integration; AdV provides high transient expression. Both are pseudotyped for optimal DC transduction.
mRNA electroporation (GFP, ovalbumin, etc.) achieves rapid, high-level expression without genomic integration. Lipid nanoparticles (LNPs) and nucleofection are also available for sensitive applications.
Knockout or knock-in of immune-related genes (e.g., PD-L1, CIITA) using CRISPR/Cas9 delivered via RNP or lentivirus to study gene function in DC biology.
Functional Validation
Confirm that your engineered DCs behave as intended.
Co-culture with antigen-specific T cells (OT-I/OT-II) or hybridomas to measure MHC-I/-II presentation via IL-2 ELISA or proliferation assays (CFSE dilution).
Allogeneic mixed lymphocyte reaction (MLR) to assess T-cell priming capacity. Cytokine profiling (IFN-γ, IL-4, IL-17) by ELISA or multiplex.
Detailed flow cytometry panels for activation markers (CD80, CD86, CD40, MHC-II), co-stimulatory molecules, and lineage markers post-modification.
In Vivo Homing & Tracking
Evaluate the migratory behavior and biodistribution of engineered DCs in animal models.
DCs can be labeled with fluorescent dyes (CFSE, Qtracker) or transduced with luciferase for bioluminescent tracking after adoptive transfer (s.c., i.v., i.d.).
Quantification of DC migration to draining lymph nodes and spleen by flow cytometry or immunohistochemistry. Chemokine receptor expression (CCR7) can be modulated.
Custom DC Engineering
For unique requirements, we offer bespoke solutions.
From multi-gene constructs (e.g., antigen + co-stimulatory ligand + reporter) to species-specific DCs (rat, rabbit, non-human primate), we adapt to your research needs.
Why Choose Creative Biolabs for DC Engineering?
Our platforms are optimized specifically for dendritic cells, delivering superior performance and reliability.
Optimized Lentiviral Systems for moDCs
Proprietary lentiviral pseudotypes and enhancers (Vpx, VSV-G) that boost transduction efficiency in human monocyte-derived DCs up to 70% while preserving viability.
Maturation-Resistant Transduction
Specially timed protocols and low-inflammatory vectors that prevent premature DC maturation during gene delivery, maintaining their native antigen-presenting capacity.
High Viability Preservation (>85%)
Serum-free, GMP-grade culture conditions and gentle handling ensure >85% viability post-modification—critical for downstream functional assays.
Custom Promoter Engineering
Choice of constitutive (EF1α, CMV), DC-specific (CD11c, DEC-205), or inducible (Tet-On) promoters to fine-tune transgene expression levels and kinetics.
End-to-End Validation Pipeline
From phenotypic analysis (CD11c, MHC-II, CD80/86) to functional T-cell activation assays (MLR, antigen presentation) — every batch is rigorously tested.
Scalable & Reproducible Production
Proprietary scalable culture system enables production of up to 50×10⁶ DCs per batch with lot-to-lot consistency, supporting large-scale studies.
Streamlined DC Engineering Workflow
From concept to validated cells in 6–8 weeks.
Project Consultation
Discuss your gene of interest, target cell type (human/murine), preferred delivery method, and functional readouts. We provide expert guidance on vector design and experimental timeline.
Vector Design & Promoter Selection
Customize your expression cassette with constitutive, DC-specific, or inducible promoters. We synthesize and clone your gene into lentiviral, adenoviral, or mRNA templates.
DC Differentiation from Monocytes
Isolate CD14+ monocytes (human) or bone marrow progenitors (mouse) and differentiate into immature DCs using standardized cytokine cocktails. Purity and phenotype are verified by flow cytometry.
Genetic Modification
Transduce or electroporate DCs with your custom vector under optimized conditions (MOI, timing, Vpx enhancement). Efficiency is monitored by reporter expression or qPCR.
Functional Validation
Assess antigen presentation (MHC-I/II upregulation), T-cell activation (MLR, antigen-specific T cell assays), and cytokine secretion (ELISA, multiplex). All data are compiled in a comprehensive report.
QC, Report & Delivery
Final QC includes viability, sterility, mycoplasma, and endotoxin testing. Engineered DCs are cryopreserved or shipped fresh with a detailed Certificate of Analysis and functional data.
Common Challenges in DC Engineering – And Our Solutions
We’ve refined our protocols to overcome the most frequent hurdles in dendritic cell modification.
| Challenges | Our Solutions |
|---|---|
| Low transduction efficiency | Vpx packaging strategy – Incorporation of Vpx in lentiviral particles degrades SAMHD1, lifting the restriction in myeloid cells and boosting efficiency up to 70% in moDCs. |
| Premature maturation | Controlled MOI & timing – Low MOI (≤5) and transduction during the immature DC stage prevent spontaneous maturation; use of maturation-resistant pseudotypes. |
| Low viability after modification | Serum-free optimized protocol – GMP-grade, serum-free media with antioxidants and reduced electroporation stress maintain viability >85%. |
| Limited expansion capacity | Scalable culture system – Feeder-free, gas-permeable culture vessels and optimized cytokine feeds allow production of up to 50×10⁶ DCs per batch. |
Technical Capabilities
Precision engineering of dendritic cells with state-of-the-art tools.
Gene Delivery Methods
We optimize each method to balance efficiency, safety, and functional integrity of DCs.
-
Lentiviral Transduction Third-generation self-inactivating vectors with VSV-G envelope; titers >10⁸ TU/mL. Protocols optimized for both human and murine DCs to achieve >60% transduction efficiency while maintaining viability.
-
mRNA Electroporation High-efficiency (>80%) transfection with minimal cytotoxicity. We provide in vitro transcribed mRNA (capped, polyadenylated) encoding your gene of interest. Ideal for transient expression of antigens or Cre recombinase.
-
Adenoviral Vectors High-capacity Ad5 vectors (E1/E3 deleted) for robust transient expression. Particularly effective for mature DCs and co-expression of multiple genes.
Functional Assays
Comprehensive panels to validate DC function post-engineering.
-
Antigen Cross-Presentation Measure cross-presentation of soluble or cell-associated antigens using B3Z or other T-cell hybridoma systems.
-
Cytokine Profiling Multiplex assays (IL-12p70, IL-10, TNF-α, IL-6) to determine DC activation/tolerogenic status.
Production & Quality
All engineered DC products are released with rigorous quality control suitable for research applications.
| Parameter | Specification | Method |
|---|---|---|
| Viability | ≥ 85% | Trypan blue / 7-AAD |
| Purity (CD11c+) | ≥ 90% | Flow cytometry |
| Transduction Efficiency | Typically 40-80% (gene dependent) | Reporter expression / qPCR |
Application Scenarios
Engineered DCs enable diverse research areas across immunology.
Immuno-Oncology Research
Generate tumor-antigen-loaded DCs to study T-cell priming, checkpoint modulation, and combination therapies in syngeneic mouse models. Evaluate novel adjuvants or delivery systems.
Autoimmunity & Tolerance
Engineer tolerogenic DCs expressing anti-inflammatory molecules (IL-10, IDO, PD-L1) to investigate mechanisms of immune suppression in models of arthritis, diabetes, or transplant rejection.
Infectious Disease & Vaccinology
Load DCs with viral/bacterial antigens (e.g., SARS-CoV-2 spike, HIV gag) to evaluate antigen processing, presentation, and induction of pathogen-specific T-cell responses.
Gene Function Studies
Knock out or overexpress specific genes in DCs (using CRISPR or cDNA) to dissect their role in migration, cytokine production, or cross-presentation.
Imaging & Tracking
DCs expressing luciferase or fluorescent reporters for real-time tracking of migration to lymph nodes and tumor sites after adoptive transfer.
Basic Immunology
Explore fundamental aspects of DC biology: antigen uptake, processing, MHC loading, and interactions with T and NK cells using genetically defined DC populations.
Why Choose Engineered DCs?
Compare DC-based gene delivery with other common research platforms.
| Delivery System | Targeting | Immunogenicity | Persistence | Best Research Use |
|---|---|---|---|---|
|
Engineered DCs
|
Active (lymph node homing) | Intrinsic adjuvant effect (mature DCs) or tolerogenic (immature/tol-DCs) | Days to weeks (depends on modification) | Studying adaptive immunity, vaccination, tolerance |
| Naked mRNA/LNP | Passive | Can be inflammatory (LNP) | Transient (days) | Rapid screening, protein replacement |
| Viral Vectors (direct injection) | Broad (off-target) | High (AdV) to low (AAV) | Variable (weeks to years) | Gene therapy, in vivo gene editing |
| Exosomes | Depends on source | Low | Short | Cell-free communication studies |
Frequently Asked Questions
Plan Your DC Engineering Project
To ensure the best results, please consider the following when requesting a quote:
- Cell Source: Human (PBMC) or murine (bone marrow)?
- Gene of Interest: Antigen, cytokine, reporter, CRISPR components?
- Delivery Method: Lentivirus, mRNA electroporation, adenovirus, LNP?
- Functional Readout: Antigen presentation, T-cell activation, migration, etc.
- Quantity & Format: Number of cells, cryopreserved or fresh?
Get a Custom Quote
Our DC engineering specialists are ready to discuss your project and provide a detailed proposal.
Start Your Project Today
Tell us about your project, and our experts will get back to you with a customized quote and proposal.
